Détail de l'auteur
Documents disponibles écrits par cet auteur (5)
Ajouter le résultat à ma sélection Faire une suggestion Affiner la recherche
Article
Lisa-M SCHWARTZ ; FOWLER (Floyd-Jjr) : USA. Center for Survey Research. University of Massachusetts. Boston. ; Hgilbert WELCH ; Steven WOLOSHIN ; Dartmouth Medical School. Center for the Evaluative Clinical Sciences. Hanover. NH. USA ; University of Massachusetts. Norris Cotton Cancer Centern. Boston. USA ; Va Outcomes Group. White River Junction. VT. USA |[BDSP. Notice produite par INIST-CNRS IsR0xt3Q. Diffusion soumise à autorisation]. Context : Public health officials, physicians, and disease advocacy groups have worked hard to educate individuals living in the United States about the importanc[...]
Article
[BDSP. Notice produite par INIST-CNRS 2iqYR0xM. Diffusion soumise à autorisation]. Context Although they are preliminary and have undergone only limited peer review, research abstracts at scientific meetings may receive prominent attention in th[...]
Article
Lisa-M SCHWARTZ ; Steven WOLOSHIN ; Norris Cotton Cancer Center. Dartmouth Hitchcock Medical Center. Lebanon. NH. USA ; Va Outcomes Group. White River Junction. USA |[BDSP. Notice produite par INIST-CNRS 5MrK4R0x. Diffusion soumise à autorisation]. Context In the late 1990s, 3 events pertaining to breast cancer prevention received considerable attention in the US news media : a National Institutes of Health [...]
Article
[BDSP. Notice produite par INIST-CNRS 5UR0xJ3y. Diffusion soumise à autorisation]. Context While medical journals strive to ensure accuracy and the acknowledgment of limitations in articles, press releases may not reflect these efforts. Methods [...]
Article
Steven WOLOSHIN ; Lisa-M SCHWARTZ ; Jennifer TREMMEL ; Hgilbert WELCH ; Norris Cotton Cancer Center. Lebanon. NH. USA ; Va Outcomes Group. Department of Veterans Affairs Medical Center. White River Junction. VT. USA |[BDSP. Notice produite par INIST-CNRS 11geRR0x. Diffusion soumise à autorisation]. Background Pharmaceutical companies spent US$1.8 billion on direct-to-consumer advertisements for prescription drugs in 1999. Our aim was to establish what messag[...]
